BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11285 related articles for article (PubMed ID: 24114802)

  • 1. Mendelian randomization analysis with multiple genetic variants using summarized data.
    Burgess S; Butterworth A; Thompson SG
    Genet Epidemiol; 2013 Nov; 37(7):658-65. PubMed ID: 24114802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods.
    Burgess S; Dudbridge F; Thompson SG
    Stat Med; 2016 May; 35(11):1880-906. PubMed ID: 26661904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.
    Bowden J; Davey Smith G; Haycock PC; Burgess S
    Genet Epidemiol; 2016 May; 40(4):304-14. PubMed ID: 27061298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.
    Burgess S; Thompson SG
    Am J Epidemiol; 2015 Feb; 181(4):251-60. PubMed ID: 25632051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.
    Bowden J; Davey Smith G; Burgess S
    Int J Epidemiol; 2015 Apr; 44(2):512-25. PubMed ID: 26050253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The many weak instruments problem and Mendelian randomization.
    Davies NM; von Hinke Kessler Scholder S; Farbmacher H; Burgess S; Windmeijer F; Smith GD
    Stat Med; 2015 Feb; 34(3):454-68. PubMed ID: 25382280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of allele scores as instrumental variables for Mendelian randomization.
    Burgess S; Thompson SG
    Int J Epidemiol; 2013 Aug; 42(4):1134-44. PubMed ID: 24062299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants.
    Burgess S; Bowden J; Fall T; Ingelsson E; Thompson SG
    Epidemiology; 2017 Jan; 28(1):30-42. PubMed ID: 27749700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of instrumental variable estimators for Mendelian randomization.
    Burgess S; Small DS; Thompson SG
    Stat Methods Med Res; 2017 Oct; 26(5):2333-2355. PubMed ID: 26282889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian approach to Mendelian randomisation with dependent instruments.
    Shapland CY; Thompson JR; Sheehan NA
    Stat Med; 2019 Mar; 38(6):985-1001. PubMed ID: 30485479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust and efficient method for Mendelian randomization with hundreds of genetic variants.
    Burgess S; Foley CN; Allara E; Staley JR; Howson JMM
    Nat Commun; 2020 Jan; 11(1):376. PubMed ID: 31953392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
    Lanktree MB; Thériault S; Walsh M; Paré G
    Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy.
    Rees JMB; Wood AM; Burgess S
    Stat Med; 2017 Dec; 36(29):4705-4718. PubMed ID: 28960498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the causal pathway from omega-6 levels to coronary heart disease: A network Mendelian randomization study.
    Liao LZ; Li WD; Liu Y; Li JP; Zhuang XD; Liao XX
    Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):233-240. PubMed ID: 31648883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Powerful three-sample genome-wide design and robust statistical inference in summary-data Mendelian randomization.
    Zhao Q; Chen Y; Wang J; Small DS
    Int J Epidemiol; 2019 Oct; 48(5):1478-1492. PubMed ID: 31298269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Adiponectin in Coronary Heart Disease Risk: A Mendelian Randomization Study.
    Borges MC; Lawlor DA; de Oliveira C; White J; Horta BL; Barros AJ
    Circ Res; 2016 Jul; 119(3):491-9. PubMed ID: 27252388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Causal Pathway From Telomere Length to Coronary Heart Disease: A Network Mendelian Randomization Study.
    Zhan Y; Karlsson IK; Karlsson R; Tillander A; Reynolds CA; Pedersen NL; Hägg S
    Circ Res; 2017 Jul; 121(3):214-219. PubMed ID: 28515044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates.
    Rees JMB; Wood AM; Dudbridge F; Burgess S
    PLoS One; 2019; 14(9):e0222362. PubMed ID: 31545794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mendelian randomization studies in coronary artery disease.
    Jansen H; Samani NJ; Schunkert H
    Eur Heart J; 2014 Aug; 35(29):1917-24. PubMed ID: 24917639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.
    Burgess S; Scott RA; Timpson NJ; Davey Smith G; Thompson SG;
    Eur J Epidemiol; 2015 Jul; 30(7):543-52. PubMed ID: 25773750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 565.